Multiple Sclerosis
Disease State Hub
Featured
11/14/2023
The FDA has approved the first biosimilar treatment for patients living with relapsing forms of multiple sclerosis.
11/14/2023
06/06/2023
A team of researchers determined the impact of obstructive sleep apnea and insomnia on cognitive decline in women with multiple sclerosis.
06/06/2023
12/16/2022
Multiple sclerosis has been described for centuries, though physicians at the time did not have a name for the condition. In what year was multiple sclerosis officially recognized in the United States? ...
12/16/2022
Interactive Features
12/16/2022
Multiple sclerosis has been described for centuries, though physicians at the time did not have a name for the condition. In what year was multiple sclerosis officially recognized in the United States? ...
12/16/2022
07/24/2020
How many minutes of exercise or lifestyle activity per week are generally recommended for patients with multiple sclerosis? Test your knowledge in our latest pop quiz!
07/24/2020
06/24/2020
Guidelines state that 6 weeks of comprehensive multidisciplinary outpatient rehabilitation may be effective for improving disability and/or function in multiple sclerosis (MS). Do you find that outpatient...
06/24/2020
06/02/2020
Cognitive changes are common among people with multiple sclerosis (MS). How do you screen for cognitive involvement among your patients with MS? Let us know by taking our poll.
06/02/2020
05/15/2020
For the initial treatment of pediatric multiple sclerosis, do you choose to treat your patients with newer or injectable disease-modifying therapies?
05/15/2020
Clinical Insights
06/10/2022
A recent study compared the use of mental health and physical health services among mothers of children with multiple sclerosis (MS) and those of children without MS. Lead researcher Ruth Ann Marrie, MD,...
06/10/2022
08/26/2020
She discusses the current state of evidence on the role of fluid and neurophysiological biomarkers in the early diagnosis of progression of relapsing-remitting MS to secondary progressive MS, and more. ...
08/26/2020
07/27/2020
In this podcast, Dr DeLuca discusses the clinical course and prognosis of cognitive impairment in relapsing-remitting multiple sclerosis, as well as cognitive rehabilitation tools that are currently...
07/27/2020
07/26/2020
Neurology Consultant spoke with Helen Tremlett, PhD, from the University of British Columbia, whose recent study adds to increasing evidence of a multiple sclerosis prodrome.
07/26/2020
07/23/2020
Mona Bostick, RDN, LDN, discusses nutrition and the role of multidisciplinary nutrition care for patients with multiple sclerosis. She recently gave a talk on this topic at the 2020 CMSC Virtual Meeting. ...
07/23/2020
